First Trust Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Buy |
94,305
+76,453
| +428% | +$1.76M | ﹤0.01% | 1781 |
|
|
2025
Q1 | $518K | Sell |
17,852
-63,277
| -78% | -$1.83M | ﹤0.01% | 2225 |
|
|
2024
Q4 | $3.01M | Buy |
81,129
+63,100
| +350% | +$2.34M | ﹤0.01% | 1632 |
|
|
2024
Q3 | $875K | Buy |
18,029
+8,319
| +86% | +$404K | ﹤0.01% | 2040 |
|
|
2024
Q2 | $388K | Sell |
9,710
-57,376
| -86% | -$2.3M | ﹤0.01% | 2169 |
|
|
2024
Q1 | $2.95M | Buy |
67,086
+20,169
| +43% | +$886K | ﹤0.01% | 1559 |
|
|
2023
Q4 | $2.9M | Sell |
46,917
-32,146
| -41% | -$1.99M | ﹤0.01% | 1566 |
|
|
2023
Q3 | $3.64M | Sell |
79,063
-22,874
| -22% | -$1.05M | ﹤0.01% | 1401 |
|
|
2023
Q2 | $5.86M | Buy |
101,937
+61,604
| +153% | +$3.54M | 0.01% | 1170 |
|
|
2023
Q1 | $1.51M | Sell |
40,333
-24,656
| -38% | -$925K | ﹤0.01% | 1819 |
|
|
2022
Q4 | $1.82M | Buy |
+64,989
| New | +$1.82M | ﹤0.01% | 1730 |
|
|
2021
Q2 | – | Sell |
-31,416
| Closed | -$584K | – | 2474 |
|
|
2021
Q1 | $584K | Sell |
31,416
-3,297
| -9% | -$61.3K | ﹤0.01% | 2164 |
|
|
2020
Q4 | $698K | Buy |
+34,713
| New | +$698K | ﹤0.01% | 2025 |
|
|
2020
Q2 | – | Sell |
-42,699
| Closed | -$634K | – | 2356 |
|
|
2020
Q1 | $634K | Sell |
42,699
-57,908
| -58% | -$860K | ﹤0.01% | 1850 |
|
|
2019
Q4 | $1.94M | Sell |
100,607
-23,909
| -19% | -$461K | ﹤0.01% | 1573 |
|
|
2019
Q3 | $2.47M | Buy |
124,516
+8,942
| +8% | +$177K | ﹤0.01% | 1413 |
|
|
2019
Q2 | $2.44M | Buy |
+115,574
| New | +$2.44M | ﹤0.01% | 1448 |
|